Inventor
WAY JEFFREY CHARLES
US17 patents
⚠️ This page may combine multiple inventors who share the name “WAY JEFFREY CHARLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HARVARD COLLEGE
12 patentsUS11203623B2Dec 21, 2021
Engineered opsonin for pathogen detection and treatment
HARVARD COLLEGE4 citations84
US11795212B2Oct 24, 2023
Engineered microbe-targeting molecules and uses thereof
HARVARD COLLEGE4 citations83
US10865235B2Dec 15, 2020
Engineered microbe-targeting molecules and uses thereof
HARVARD COLLEGE2 citations71
US10308697B2Jun 4, 2019
Fusion proteins for treating cancer and related methods
HARVARD COLLEGE1 citations68
US10047405B2Aug 14, 2018
Engineered genetic enteric sensor bacteria and uses thereof
HARVARD COLLEGE4 citations65
US11059874B2Jul 13, 2021
Engineered opsonin for pathogen detection and treatment
HARVARD COLLEGE0 citations62
US11059873B2Jul 13, 2021
Engineered opsonin for pathogen detection and treatment
HARVARD COLLEGE0 citations62
US11014973B2May 25, 2021
Fusion proteins for treating cancer and related methods
HARVARD COLLEGE0 citations57
US10907221B2Feb 2, 2021
Engineered genetic enteric sensor bacteria and uses thereof
HARVARD COLLEGE0 citations53
US10538562B2Jan 21, 2020
Engineered opsonin for pathogen detection and treatment
HARVARD COLLEGE0 citations52
US10526399B2Jan 7, 2020
Engineered microbe-targeting molecules and uses thereof
HARVARD COLLEGE0 citations50
US10538566B2Jan 21, 2020
Fusion proteins for treating cancer and related methods
HARVARD COLLEGE0 citations47
VERTEX PHARMA
3 patentsUS12116606B2Oct 15, 2024
Complement factor I-related compositions and methods
VERTEX PHARMA0 citations50
US12331334B2Jun 17, 2025
Modified urokinase-type plasminogen activator polypeptides and methods of use
VERTEX PHARMA0 citations47
US11613744B2Mar 28, 2023
Modified urokinase-type plasminogen activator polypeptides and methods of use
VERTEX PHARMA0 citations47